FRIDAY, March 11, 2022 (HealthDay Information) — Girls stricken by frequent urinary tract infections usually take each day antibiotics to ward them off. However an previous antibiotic different would possibly work simply as effectively, a brand new medical trial finds.
Researchers discovered that the medicine, referred to as methenamine, was comparable to straightforward, low-dose antibiotics in stopping ladies’s recurrent urinary tract infections (UTIs). Both therapy curbed the infections to round one per 12 months, on common.
Methenamine is a long-established medicine that works by making the urine extra acidic and stopping bacterial progress. Research have proven that it could stop recurrent UTIs, nevertheless it’s not extensively used.
It is such an “previous” drug, many medical doctors in the present day have no idea about it, stated Dr. Karyn Eilber, a urologist at Cedars-Sinai Medical Heart in Los Angeles.
Eilber, who was not concerned within the new examine, stated she reserves each day antibiotics as a final resort for stopping recurrent UTIs, favoring methenamine as a substitute.
A priority with each day antibiotic use is feeding antibiotic resistance, the place micro organism study to thwart the drugs used to kill them. Plus, Eilber stated, it disrupts the physique’s regular bacterial stability.
Dr. Chris Harding, a advisor urological surgeon at Freeman Hospital in the UK, led the trial.
He stated it “provides supportive proof for the usage of methenamine and will probably be significantly welcome to these ladies with recurrent UTI who wish to keep away from long-term antibiotic therapy.”
UTIs are exceedingly widespread and may have an effect on anybody, however are significantly prevalent amongst ladies. Research counsel as much as 80% of ladies develop a UTI in some unspecified time in the future, and about one-quarter of these ladies go on to have frequent recurrences.
Some signs embrace burning throughout urination, and feeling a powerful, persistent urge to urinate.
The brand new examine — revealed on-line March 9 within theBMJ— concerned 240 ladies with recurring UTIs. Firstly, they had been averaging round six UTIs per 12 months.
Half of the ladies had been randomly assigned to each day low-dose antibiotic therapy, whereas the opposite half took methenamine twice a day.
Over one 12 months of therapy, each teams noticed a major decline in UTI episodes. Girls within the antibiotic group averaged just below one bout per particular person for the 12 months, whereas these taking methenamine had simply over one episode per particular person.
That could be a small distinction, Harding stated, and one which, based mostly on affected person focus teams, wouldn’t be thought of “clinically significant.”
As for unwanted side effects, a small variety of ladies in every group reported issues like nausea, belly ache and diarrhea. Six ladies developed a UTI with fever, and 4 wanted to be hospitalized — all of whom had been within the methenamine group.
Whether or not treating extra UTIs with methenamine will assist battle the issue of antibiotic resistance is an open query. In the course of the one 12 months of therapy on this trial, ladies on antibiotics had been extra prone to harbor micro organism immune to not less than one antibiotic. However that modified when their micro organism had been sampled six months later: Those that had taken methenamine had extra antibiotic-resistant bugs.
Harding stated that discovering “needs to be interpreted with warning,” for the reason that trial was not primarily geared toward gauging antibiotic resistance.
“Additional analysis is unquestionably indicated on this space,” he stated.
For now, ladies ought to know there are alternatives for stopping frequent UTIs, the specialists stated.
“Low-dose antibiotics ought to undoubtedly not be the primary line,” Eilber stated.
In addition to methenamine, one other different is to take an antibiotic solely after intercourse. (Sexual exercise can encourage UTI-causing micro organism to maneuver into the urethra, the tube that releases urine from the physique.)
For postmenopausal ladies, Eilber stated, vaginal estrogen could assist stop recurrent UTIs. After menopause, the vaginal tissue adjustments in ways in which could foster the expansion of “dangerous” micro organism.
Consultants additionally usually advise some self-care steps that may assist, like consuming loads of water, urinating earlier than and after intercourse, and wiping entrance to again after utilizing the toilet.
Most of the ladies within the present trial had been going via or previous menopause. However, Harding stated, his staff didn’t have a look at the consequences of therapy in response to age. Nor did the examine embrace males. So it isn’t clear whether or not the findings would apply to older adults, one other group at elevated threat of recurrent UTI.
The examine was funded by the U.Ok. Nationwide Institute for Well being Analysis.
Extra info
The U.S. Workplace on Girls’s Well being has extra on urinary tract infections.
SOURCES: Chris Harding, MD, advisor urological surgeon, Freeman Hospital, Newcastle upon Tyne, U.Ok.; Karyn Eilber, MD, urologist, Cedars-Sinai Medical Heart, Los Angeles; BMJ, March 9, 2022, on-line